Identification and Characterization of Novel CFTR Potentiators

There is still a high unmet need for the treatment of most patients with cystic fibrosis (CF). The identification and development of new Cystic Fibrosis Transmembrane conductance Regulator (CFTR) modulators is necessary to achieve higher clinical benefit in patients. In this report we describe the c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Gees, Maarten, Musch, Sara, Van der Plas, Steven, Wesse, Anne-Sophie, Vandevelde, Ann, Verdonck, Katleen, Mammoliti, Oscar, Hwang, Tzyh-Chang, Sonck, Kathleen, Stouten, Pieter, Swensen, Andrew M., Jans, Mia, Van der Schueren, Jan, Nelles, Luc, Andrews, Martin, Conrath, Katja
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6212544/
https://ncbi.nlm.nih.gov/pubmed/30416447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.01221
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados